Brief: Dicot Reports Positive Results From Study With Drug Candidate Libiguin

Dicot Pharma AB

14/09/2020 09:32

Sept 14 (Reuters) - Dicot AB  DICOT.TE :
    * DICOT REPORTS POSITIVE RESULTS FROM STUDY WITH THE DRUG
CANDIDATE LIBIGUIN® FOR THE TREATMENT OF SEXUAL DYSFUNCTIONS
    * RESULTS SHOW THAT DICOT'S DRUG CANDIDATE LIBIGUIN® HAD A
SIGNIFICANT AND DOSE-DEPENDENT EFFECT ON ERECTION COMPARED TO
PLACEBO AT ALL MEASURED PARAMETERS IN PELVIPHARM'S ESTABLISHED
ANIMAL MODEL

Source text for Eikon:  ID:nWkr355Vn4 
Further company coverage:  DICOT.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))